|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net income/(loss) | |||||
| Adjustments to reconcile net loss to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Impairment of goodwill | |||||
| Operating lease right-of-use assets amortization expense | |||||
| Bad debt expense | |||||
| Stock-based compensation | |||||
| Deferred income taxes | |||||
| Change in fair value of contingent consideration | |||||
| Other income, net | |||||
| Changes in assets and liabilities: | |||||
| Trade receivable | |||||
| Increase (Decrease) in Contract with Customer, Asset | |||||
| Prepaid income taxes | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable | |||||
| Accrued compensation and benefits | |||||
| Operating lease liabilities | |||||
| Income taxes, net | |||||
| Accrued expenses and other current liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities | |||||
| Purchase of property and equipment | |||||
| Proceeds from sale of equity securities | |||||
| Purchase of equity securities | |||||
| Acquisition of business, net of cash acquired | |||||
| Other investing activities, net | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities | |||||
| Proceeds from exercises of stock options | |||||
| Payments of tax obligations resulted from net share settlement of vested stock awards | |||||
| Payment of contingent consideration related to previously acquired businesses | |||||
| Proceeds from debt | |||||
| Proceeds from exercise of warrants | |||||
| Repayment of debt | |||||
| Debt issuance cost | |||||
| Payments for repurchases of common stock | |||||
| Debt and equity issuance costs | |||||
| Proceeds from common stock offering | |||||
| Net cash (used in)/provided by financing activities | |||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | |||||
| Net increase in cash, cash equivalents, and restricted cash | |||||
| Cash, cash equivalents and restricted cash, beginning of period | |||||
| Cash, cash equivalents and restricted cash, end of period | |||||
| Cash paid for income taxes | |||||
| Cash paid for income taxes, net of refunds | |||||
| Supplemental disclosure of non-cash activities | |||||
| Acquisition fair value of contingent consideration issued for acquisition of business | |||||
| Balance sheet classification | |||||
| Cash and cash equivalents | |||||
| Restricted cash | |||||
Loading...